297 related articles for article (PubMed ID: 30481277)
61. Inhibition of lysophosphatidic acid receptor ameliorates Sjögren's syndrome in NOD mice.
Park E; Kim D; Lee SM; Jun HS
Oncotarget; 2017 Apr; 8(16):27240-27251. PubMed ID: 28460477
[TBL] [Abstract][Full Text] [Related]
62. MUC19 expression in human ocular surface and lacrimal gland and its alteration in Sjögren syndrome patients.
Yu DF; Chen Y; Han JM; Zhang H; Chen XP; Zou WJ; Liang LY; Xu CC; Liu ZG
Exp Eye Res; 2008 Feb; 86(2):403-11. PubMed ID: 18184611
[TBL] [Abstract][Full Text] [Related]
63. Lacrimal and salivary gland inflammation in the C3H/Ipr autoimmune strain mouse: a potential mode for Sjögren's syndrome.
Johnson BC; Morton JI; Trune DR
Otolaryngol Head Neck Surg; 1992 Apr; 106(4):394-9. PubMed ID: 1565490
[TBL] [Abstract][Full Text] [Related]
64. A MZB Cell Activation Profile Present in the Lacrimal Glands of Sjögren's Syndrome-Susceptible C57BL/6.NOD-
Peck AB; Nguyen CQ; Ambrus JL
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682784
[TBL] [Abstract][Full Text] [Related]
65. Altered expression of genes functioning in lipid homeostasis is associated with lipid deposition in NOD mouse lacrimal gland.
Wu K; Joffre C; Li X; MacVeigh-Aloni M; Hom M; Hwang J; Ding C; Gregoire S; Bretillon L; Zhong JF; Hamm-Alvarez SF
Exp Eye Res; 2009 Sep; 89(3):319-32. PubMed ID: 19345210
[TBL] [Abstract][Full Text] [Related]
66. A Multivalent ICAM-1 Binding Nanoparticle which Inhibits ICAM-1 and LFA-1 Interaction Represents a New Tool for the Investigation of Autoimmune-Mediated Dry Eye.
Hsueh PY; Ju Y; Vega A; Edman MC; MacKay JA; Hamm-Alvarez SF
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326657
[TBL] [Abstract][Full Text] [Related]
67. Animal models for autoimmune disease-associated xerostomia and xerophthalmia.
Humphreys-Beher MG
Adv Dent Res; 1996 Apr; 10(1):73-5. PubMed ID: 8934930
[TBL] [Abstract][Full Text] [Related]
68. Detection of Grb-2-related adaptor protein gene (GRAP) and peptide molecule in salivary glands of MRL/lpr mice and patients with Sjögren's syndrome.
Shiraiwa H; Takei M; Yoshikawa T; Azuma T; Kato M; Mitamura K; Ueki T; Kida A; Horie T; Seki N; Sawada S
J Int Med Res; 2004; 32(3):284-91. PubMed ID: 15174222
[TBL] [Abstract][Full Text] [Related]
69. The Effect of Chloroquine on the Development of Dry Eye in Sjögren Syndrome Animal Model.
Lee HJ; Shin S; Yoon SG; Cheon EJ; Chung SH
Invest Ophthalmol Vis Sci; 2019 Sep; 60(12):3708-3716. PubMed ID: 31479110
[TBL] [Abstract][Full Text] [Related]
70. Lacrimal Gland Epithelial Cells Shape Immune Responses through the Modulation of Inflammasomes and Lipid Metabolism.
Delcroix V; Mauduit O; Yang M; Srivastava A; Umazume T; de Paiva CS; Shestopalov VI; Dartt DA; Makarenkova HP
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901740
[TBL] [Abstract][Full Text] [Related]
71. Paradoxic effect of anti-CD4 therapy on lacrimal gland disease in MRL/Mp-lpr/lpr mice.
Jabs DA; Burns WH; Prendergast RA
Invest Ophthalmol Vis Sci; 1996 Jan; 37(1):246-50. PubMed ID: 8550330
[TBL] [Abstract][Full Text] [Related]
72. The miRNA Landscape of Lacrimal Glands in a Murine Model of Autoimmune Dacryoadenitis.
Singh Kakan S; Li X; Edman MC; Okamoto CT; Hjelm BE; Hamm-Alvarez SF
Invest Ophthalmol Vis Sci; 2023 Apr; 64(4):1. PubMed ID: 37010857
[TBL] [Abstract][Full Text] [Related]
73. Lacrimal Gland Inflammation Deregulates Extracellular Matrix Remodeling and Alters Molecular Signature of Epithelial Stem/Progenitor Cells.
Umazume T; Thomas WM; Campbell S; Aluri H; Thotakura S; Zoukhri D; Makarenkova HP
Invest Ophthalmol Vis Sci; 2015 Dec; 56(13):8392-402. PubMed ID: 26747770
[TBL] [Abstract][Full Text] [Related]
74. Blueberry Leaf Extract Prevents Lacrimal Hyposecretion in Sjögren's Syndrome-like Model of Non-obese Diabetic Mice.
Ogawa K; Urata K; Maeda S; Ohno Y; Satoh K; Yamada Y; Suzuki Y; Koga Y; Sugamoto K; Kawaguchi M; Kunitake H; Nishiyama K; Goto YO; Nakayama T; Yamasaki M
In Vivo; 2023; 37(1):149-162. PubMed ID: 36593026
[TBL] [Abstract][Full Text] [Related]
75. Early pathogenic events associated with Sjögren's syndrome (SjS)-like disease of the NOD mouse using microarray analysis.
Killedar SJ; Eckenrode SE; McIndoe RA; She JX; Nguyen CQ; Peck AB; Cha S
Lab Invest; 2006 Dec; 86(12):1243-60. PubMed ID: 17075579
[TBL] [Abstract][Full Text] [Related]
76. Differential expression of adenylyl cyclase mRNAs in lacrimal glands of NZB/NZW and NOD pre-autoimmune mice.
Meneray MA; Lallier TE
Adv Exp Med Biol; 2002; 506(Pt A):41-9. PubMed ID: 12613887
[No Abstract] [Full Text] [Related]
77. Unique ultrastructure of exorbital lacrimal glands in male NOD and BALB/c mice.
Ding C; MacVeigh M; Pidgeon M; da Costa SR; Wu K; Hamm-Alvarez SF; Schechter JE
Curr Eye Res; 2006 Jan; 31(1):13-22. PubMed ID: 16421015
[TBL] [Abstract][Full Text] [Related]
78. Autoimmune dacryoadenitis of NOD/LtJ mice and its subsequent effects on tear protein composition.
Doyle ME; Boggs L; Attia R; Cooper LR; Saban DR; Nguyen CQ; Peck AB
Am J Pathol; 2007 Oct; 171(4):1224-36. PubMed ID: 17823290
[TBL] [Abstract][Full Text] [Related]
79. Lacrimation and salivation are not related to lymphocytic infiltration in lacrimal and salivary glands in MRL lpr/lpr mice.
Fujita H; Fujihara T; Takeuchi T; Saito I; Tsubota K
Adv Exp Med Biol; 1998; 438():941-8. PubMed ID: 9634991
[No Abstract] [Full Text] [Related]
80. Epigallocatechin gallate stimulates the neuroreactive salivary secretomotor system in autoimmune sialadenitis of MRL-Fas(lpr) mice via activation of cAMP-dependent protein kinase A and inactivation of nuclear factor κB.
Saito K; Mori S; Date F; Hong G
Autoimmunity; 2015; 48(6):379-88. PubMed ID: 25847253
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
